REQUEST A DEMO
Total
USD $0.00
Search more companies

CSPC Pharmaceutical Group Limited (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: CSPC Pharmaceutical Group Limited Profile Updated: May 06, 2020
Buy our report for this company USD 29.95 Most recent financial data: 2019 Available in: English & Chinese Download a sample report

CSPC Pharmaceuticals Group Ltd., formerly known as China Pharmaceutical Group Limited, is an investment holding company principally engaged in the manufacture and sale of pharmaceutical products. The Company is operating in three business segments: manufacture and sale of intermediate and bulk drugs which includes vitamin C series and antibiotics series; finished drugs which includes amoxicillin and cefazolin in different dosage and form, and other pharmaceutical related businesses and development activities.

Headquarters
Room 3206, 32nd Floor, Central Plaza, 18 Harbour Road, Wanchai, Hong Kong
Hong Kong; Hong Kong;

Contact Details: Purchase the CSPC Pharmaceutical Group Limited report to view the information.

Website: http://www.cspc.com.hk

Basic Information
Total Employees:
Purchase the CSPC Pharmaceutical Group Limited report to view the information.
Outstanding Shares:
Purchase the CSPC Pharmaceutical Group Limited report to view the information.
Registered Capital:
Purchase the CSPC Pharmaceutical Group Limited report to view the information.
Financial Auditors:
Purchase the CSPC Pharmaceutical Group Limited report to view the information.
Incorporation Date:
January 01, 1959
Key Executives
Purchase this report to view the information.
Executive Director
Purchase this report to view the information.
Executive Director
Purchase this report to view the information.
Executive Director
Purchase this report to view the information.
Executive Director
Purchase this report to view the information.
Executive Director
Ownership Details
Purchase this report to view the information.
23.16%
Purchase this report to view the information.
6.79%
Purchase this report to view the information.
5%
Subsidiaries
AlaMab Therapeutics, Inc. (United States)
100%
CSPC Dophen Corporation (United States)
100%
CSPC Healthcare Limited (United States)
100%
Company Performance
Financial values in the chart are available after CSPC Pharmaceutical Group Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HKD. Absolute financial data is included in the purchased report.
Net sales revenue
24.76%
Total operating revenue
24.76%
Operating profit (EBIT)
20.33%
EBITDA
19.26%
Net Profit (Loss) for the Period
22.07%
Total assets
13.36%
Total equity
25.68%
Operating Profit Margin (ROS)
-0.77%
Net Profit Margin
-0.37%
Return on Equity (ROE)
-0.56%
Debt to Equity Ratio
0.51%
Quick Ratio
0.31%
Cash Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?